Delivery Order SPE2DB22D3011-SPE2DB25FQ2NT
Award Date 9/3/25
Potential Completion Date 9/24/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count units) with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Prevymis (letermovir) 120 mg pellet packets in quantities of 30 units. The contract, valued at $5,599.72, is structured as a firm fixed price delivery order with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets on August 5, 2025, with a ceiling value of $9,438.70. This firm fixed price delivery order, which is not set aside for any specific business category, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. PREVYMIS (letermovir) is an antiviral medication primarily used for cytomegalovirus prophylaxis in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) valued at $4,719.34 under firm fixed pricing. The award was made on August 13, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a delivery order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at approximately $1 billion through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $28,316.04 to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 mg tablets (quantity 7s) to be performed in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive, non-set-aside procurement. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging) with a ceiling value of $4,719.34. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for ultimate completion by August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $9,438.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...